FitLife Brands Files 8-K/A Amendment
Ticker: FTLF · Form: 8-K/A · Filed: Oct 20, 2025 · CIK: 1374328
Sentiment: neutral
Topics: amendment, filing, exhibits
TL;DR
FitLife Brands filed an amendment to an 8-K, mostly for exhibits. Nothing major changed.
AI Summary
FitLife Brands, Inc. filed an amendment (8-K/A) on October 20, 2025, to its report originally dated August 8, 2025. This amendment primarily concerns the filing of financial statements and exhibits, with no specific new financial figures or material events detailed in the provided text.
Why It Matters
This filing indicates an update or correction to a previous report, which could be important for investors reviewing the company's official disclosures.
Risk Assessment
Risk Level: low — The filing is an amendment to a previous report and does not introduce new material financial information or significant events.
Key Players & Entities
- FITLIFE BRANDS, INC. (company) — Registrant
- August 8, 2025 (date) — Date of earliest event reported
- October 20, 2025 (date) — Filing date of the amendment
- 5214 S. 136th Street, Omaha, Nebraska 68137 (address) — Principal executive offices
FAQ
What is the purpose of this 8-K/A filing?
The 8-K/A filing is an amendment to a previous report, specifically concerning the filing of financial statements and exhibits.
What was the original report date that this amendment refers to?
The original report date was August 8, 2025.
When was this amendment filed?
This amendment was filed on October 20, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at 5214 S. 136th Street, Omaha, Nebraska 68137.
What is the company's state of incorporation?
The company is incorporated in Nevada.
Filing Stats: 906 words · 4 min read · ~3 pages · Grade level 10.6 · Accepted 2025-10-20 07:30:15
Key Financial Figures
- $0.01 — h registered Common Stock , par value $0.01 per share FTLF Nasdaq Capital Market
- $42.5 million — l consideration for the acquisition was $42.5 million. This Amendment No. 1 (this " Amendmen
Filing Documents
- ftlf20251012_8ka.htm (8-K/A) — 29KB
- ex_869746.htm (EX-99.1) — 84KB
- ex_869182.htm (EX-99.2) — 76KB
- ex_869747.htm (EX-99.3) — 38KB
- ex_869748.htm (EX-99.4) — 401KB
- 0001437749-25-031312.txt ( ) — 810KB
- ftlf-20250808.xsd (EX-101.SCH) — 3KB
- ftlf-20250808_def.xml (EX-101.DEF) — 12KB
- ftlf-20250808_lab.xml (EX-101.LAB) — 15KB
- ftlf-20250808_pre.xml (EX-101.PRE) — 12KB
- ftlf20251012_8ka_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (a) Financial statements of business acquired. (i) Audited abbreviated statement of assets acquired and liabilities assumed and notes of the Nutritional Supplement Business of Irwin Naturals, Inc. as of August 8, 2025, filed as Exhibit 99.1 hereto and incorporated by reference herein; (ii) Audited abbreviated statements of revenue and direct expense and notes of the Nutritional Supplement Business of Irwin Naturals, Inc., for the years ended December 31, 2024 and 2023, filed as Exhibit 99.2 hereto and incorporated by reference herein; and (iii) Unaudited abbreviated statements of revenue and direct expense and notes of the Nutritional Supplement Business of Irwin Naturals, Inc. for the six months ended June 30, 2025 and 2024, filed as Exhibit 99.3 hereto and incorporated by reference herein. (b) Pro forma financial information. (i) Unaudited pro forma condensed combined financial statements and notes for the Company and the Nutritional Supplement Business of Irwin Naturals, Inc. as of June 30, 2025, and for the six months ended June 30, 2025 and fiscal year ended December 31, 2024, filed as Exhibit 99.4 hereto and incorporated by reference herein. (d) Exhibits. 99.1 Audited abbreviated statement of assets acquired and liabilities assumed and notes of the Nutritional Supplement Business of Irwin Naturals, Inc. as of August 8, 2025. 99.2 Audited abbreviated statements of revenue and direct expense and notes of the Nutritional Supplement Business of Irwin Naturals, Inc., for the years ended December 31, 2024 and 2023. 99.3 Unaudited abbreviated statements of revenue and direct expense and notes of the Nutritional Supplement Business of Irwin Naturals, Inc. for the six months ended June 30, 2025 and 2024 99.4 Unaudited pro forma condensed combined financial statements and notes for the Company and the Nutritional Supplement Business of Irwin Naturals, Inc. as of June 30, 2025, and for the six months
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. FitLife Brands, Inc. October 20, 2025 /s/ Dayton Judd Dayton Judd Chief Executive Officer